pharmacie et médicaments – Plafond de remise applicable aux médicaments génériques

This written question concerns the rebate cap applicable to generic medicines in France. It seeks clarification on the financial mechanisms affecting the pricing and accessibility of these essential drugs. The question is posed by a French Member of Parliament, likely impacting pharmaceutical companies, healthcare providers, and patients who rely on generic medications.